First efficacy findings from a randomized phase III trial of capecitabine + oxaliplatin vs. bolus 5-FU / LV for stage III colon cancer (NO16968/XELOXA study). - Haller,D.; Tabernero,J.; Maroun,J. (Eur J Cancer, 2009)